Abeona Therapeutics (ABEO) Equity Ratio (2011 - 2026)

Abeona Therapeutics' Equity Ratio history runs 16 years deep, the most recent figure standing at 0.73 for Q1 2026.

• In Q1 2026, Equity Ratio rose 75.27% year-over-year to 0.73; the TTM figure through Mar 2026 stood at 0.73 (up 75.27% YoY), while the FY2025 annual figure was 0.73, up 79.39% from the prior year.
• Equity Ratio was 0.73 for Q1 2026 at Abeona Therapeutics, up from 0.73 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.74 in Q3 2025 to a low of 0.12 in Q1 2024.
• Historically, Equity Ratio has averaged 0.41 across 5 years, with a median of 0.38 in 2022.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio tumbled 133.78% in 2024, then jumped 451.02% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.42 in 2022, then sank by 44.41% to 0.23 in 2023, then soared by 74.49% to 0.4 in 2024, then jumped by 79.39% to 0.73 in 2025, then rose by 0.7% to 0.73 in 2026.
• The last three Equity Ratio figures came in at 0.73 (Q1 2026), 0.73 (Q4 2025), and 0.74 (Q3 2025), per Business Quant data.